Beyond - a digital engagement consultancy - london, new york, san francisco

Tight regulation coupled with the current lack of clear guidelines from the FDA on what pharma companies can and can’t do on sites like Facebook has made many companies hesitant to join (or stay on) these platforms, even as data shows that an increasing number of patients are turning to social networking sites for health information. At Beyond, we’ve been working with several leading Pharma companies to come up with a solution: a moderated Facebook Wall alternative we’re calling the PharModerator. This application provides Pharma companies with complete control over the content on their Page – allowing administrators to engage in meaningful dialogue with consumers, while allowing regulatory teams to sleep at night. Continue reading